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Background: Glycaemic control is the main goal of treatment for type 2 diabetic patients. Hyperglycaemia may
result in cognitive decline. More family support may increase medication adherence and decrease glycaemic level.
The purpose of this study was to determine the impact of family support improvement behavior on anti diabetic
medication adherence and cognition in type 2 diabetic patients.
Method: The randomized control trial study was conducted on 91 patients from an outpatient diabetes clinic.
They were randomly divided to intervention (n = 45) and control (n = 46) group. Data on the patients’ demographic
information and their family gathered using a questionnaire, For two groups Morisky Medication Adherence Scale
(MMAS), drug administration part of Diabetes Social Support Questionnaire – family version (DSSQ), Number
Connection Test (NCT) were applied and hemoglobin A1C was measured two times in the onset of study and three
months later for control group and before and after intervention for intervention group. The key family members of
the intervention group were taught according to their educational needs in small groups.
Result: In intervention group mean of NCT score was significantly decreased after intervention (P = 0.006) however
in the control group there was no significant difference after three months. In intervention group a significant
correlation was noted between DSSQ scores and MMAS scores after intervention(r =0.67, P < 0.001) but, there was
no significant correlation in the control group.
Conclusion: Family support instruction based on the educational needs of family members, may improve
medication adherence through direct effect and cognitive status with indirect effect.
Keywords: Diabetes mellitus type 2, Family support, Medication adherence, Cognition disorderIntroduction
Diabetes mellitus is a growing worldwide epidemic concern
with an estimated number of 330 million by the year 2030
[1]. The results of epidemiological studies in Iran showed
that the incidence of diabetes is 5%-8% (approximately 4
million people) of population [2].
Glycaemic control is one of the main goals of treatment
for diabetic patients. Poor glycaemic control is a significant
challenge in management of type 2 diabetes, with 36% to
69% of patients [3-6] failing to reach glycaemic control
targets. Among effective factors on glycaemic control such* Correspondence: f_madarshahian@yahoo.com
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article, unless otherwise stated.as medication adherence, diabetes treatment, family sup-
port [7], factors that affect teaching learning process such
as cognitive function [8-10] must be considered.
Chronic hyperglycaemia appears to be independently
associated with cognitive function in individuals with
diabetes [11]. Cognitive dysfunction in diabetic patients is
known to have an important role on patients’ adherence to
diabetes treatment [12]. Glycaemic level can cause slight or
permanent Cognitive dysfunction and also diabetes can
cause metabolic and micro vascular change on the brain
and increase the risk of stroke [13]. Early and intensive
glycaemic control is necessary to prevent or minimize
the development of microvascular and macrovascular
complications in individuals with type 2 diabetes mellitusMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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outcomes in diabetes [15]. Nonadherence has been a
recognized, persistent problem over the past 3 decades
despite numerous informational, educational and behav-
ioral interventions to promote better patients’ compliance,
particularly with medication [16].
Medication adherence is a complex behavior related to
and dependent upon many intrinsic patient risk and
extrinsic (contextual) factors [17]. Adherence to prescribed
medication requires a complex management process
scheduling, adjusting to schedule changes, planning for
availability of medication, remembering past events and
problem solving around missed/late does [18]. While
health care worker plays a role in delivering diabetes
care and education patients, approach alone has been
woefully inadequate [19]. Evidence suggests that family
member can contribute to or buffer the deleterious
effects of stress on glycaemic control. Although family
members can provide many kinds of social support (e.g.,
emotional, informational and appraisal support) and
instrumental support (e.g., observable actions that make it
possible or easier for an individual to perform healthy
behaviors) has been most strongly associated with adher-
ence to self care behaviors across chronic disease [20].
Members of supportive families are more likely to have
healthier behaviors, higher medication adherence and
lower levels of stress that could explain their superior
outcomes. Thus involving family members may improve
the diabetes management. [21]. Although the results of
some studies show that there is a correlation between
degree of family support and clinical outcome, little
research has focused on the effectiveness of family partner-
ship intervention care for patient with poorly controlled
type 2 diabetes [1] and also its indirect effect on improving
cognitive status through a direct effect on increasing
medication adherence. Family members may have a
positive or negative effect on the self care of diabetic
patients; therefore the purpose of this study was to
determine the impact of family support improvement
behaviors on anti diabetic medication adherence and
cognition in type 2 diabetic patients.
Methods
Study participants and design
In this randomized clinical trial, 91 patients with type 2
diabetes who attended the diabetes clinic of the diabetes
research center affiliated to Birjand medical university and
lived with their family in 2013 were recruited (Birjand is
one of the eastern cities in Iran with approximately
290000 people). Key family members were defined as
those over 18 years old, having a blood relative and to be
living with patient and were identified by the patient.
The inclusion criteria of the patients in the study were
the age of over 30 years old, a history of type 2 diabetesmore than one year (diagnosed by an endocrinologist),
at least three last hemoglobin A1c reading equal or above
7% in the previous 12 months, besides no intention to
change their lifestyle in the next 3 months (diet, exercise,
medication, travel,), taking oral hypoglycaemic agents,
insulin or both, and also more than 5 years schooling.
Those with severe vision and hearing problems, stroke,
any endocrine disorder could interfere with cognition and
severe cardiovascular diseases that could interfere with
Number Connection Test (NCT) performance or were
known risk factors for cognitive impairment were excluded.
The intervention and control groups were comprised of 45
and 46 patients with type 2 diabetes respectively, who had
medium or low adherence score according to Morisky
Medication Adherence Scale (MMAS) [22], and had at
least one “never” answer in the Diabetes Social Support
Questionnaire (DSSQ) - family version [23].
Patients who met the inclusion criteria were randomly
allocated to an intervention groups (n = 45) and control
group (n = 46).
Participants were matched for sex, age, education, dia-
betes duration through group matching.
Measurement and study variable
The patients’ demographic information, the number of
family members who lived with them, type of treatment
and “diabetes duration” (defined as the time between
the diagnosis of diabetes mellitus and when NCT was
performed) were extracted by one of the researchers.
Data on the patients’ demographic information and
family member gathered using a questionnaire.
MMAS is the 8-items easy to administered scale for
medication adherence, with 7 yes/no items. Each yes
response receives one point, while a no response receives 0
points. There is also one item with 5-point Likert-type
response scales ranking from never to always. The response
of never receives 1 point, while the remaining responses
receive 0 point. The MMAS has a score range of 0–8, with
higher numbers representing better adherence. The MMAS
can also be categorized into 3 levels of adherence including
high (score = 8), medium (score range, 6–7) and low (score,
0–5) [24,25]. The validity and reliability of MMAS has been
approved in previous studies [24,25].
DSSQ-family version measures the perceived family
support for adolescents diabetes care in four areas of
diabetes management: drug administration, blood glucose
testing, meals, and exercise. In this study drug administra-
tion domain, was considered and the patients only com-
pleted 8 questions of drug administration. The scoring was
done based on 1–5 points dedicated to responses of never
to always (Score range 8–40). The never response of the
patients to at least one question stood for non supportive
family in this study. The validity and reliability of DSSQ-
family has been approved in previous studies [23].







Age (y) 52.93 ± 7.62 54.13 ± 7.56 −0.75 0.45
Sex (n%)
Female 23(51.1) 25(54.3) 0.09 0.75
Male 22(48.9) 21(45.7)
Married (n%)*




9.71 ± 6.75 11.39 ± 5.4 −1.31 0.19
Education (n%)
High school 37(82.2) 36(78.3) 0.22 0.63
Higher 8(16.8) 10(21.7)
*Result exact of Fisher test.
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cognitive status (The mental process of acquiring know-
ledge and comprehension) of participants. This standard
test consists of 25 circles distributed over a sheet of
paper. It has different forms according to numbers and
similar according to hardship. For performing this test,
first the task to be accomplished was explained to the
patient using demonstration test sheet then the second
test sheet was completed by the patient. Test time was
recorded by a stopwatch in seconds (15-30 = normal,
31-50 = slight, 51-80 = moderate, 81-120 = severe and
upper to 120 = disable) [26,27].
All above examinations were performed for both inter-
vention and control group in the onset of study. For par-
ticipants who were in the intervention group, Educational
needs on non supportive family items and key family
member were determined. Then, the key persons of family
members in intervention group divided to small groups
(2–20 persons) according to their educational needs and
were taught.
The instruction about the importance of medication
adherence and family support behavior was carried
out about 45–60 minutes in 3 sessions by one of the
researchers. In every session 30–45 minutes consid-
ered for teaching and 15 minutes was allocated for
answering the questions and exchanging of views
between family members. The control group did not
receive any instruction.
After 3 months, MMAS, DSSQ, NCT and hemoglobin
A1C tests were performed in two groups. Venus blood
samples for testing HbA1c were obtained after fasting
and were analyzed on the same day in one laboratory.
Statistical analysis
Data were analyzed using the statistical package for social
science (SPSS software version 16, inc,chicaogo, IL, USA)
in which p ≤ 0.05 was considered as statistically significant.
After determining the normality of data with Kolmogrove-
Smirono test, data was analyzed for descriptive statistics,
i.e. frequency distribution, mean and standard deviation
and inferential statistics as follow:
Independent T test was used to compare age, duration
of diabetes, hemoglobin A1c, NCT results, MMAS score,
DSSQ scores between two groups and also, mean change
of hemoglobin A1c, NCT score, MMAS score, DSSQ
scores before intervention and after between two groups.
Paired T test was used to compare hemoglobin A1C,
NCT results, MMAS score, and DSSQ scores before and
after intervention for intervention group and first and
second assess for control group.
Chi square test was used to compare the literacy status
and sex between two groups. Pearson correlation test
was used for DSSQ scores, and MMAS, NCT scores,
hemoglobin A1c, age diabetes duration in two groups.Fisher exact test was used to compare married status
between two groups.
Ethical aspect
This research was approved by ethic committee of Birjand
university of medical science (no:9205). Each participant
provided written consent. Participant data were associated
with numbers rather than participant names.
Results
Ninety one diabetic men and women (age range 34–74,
mean age: 53.53 ± 7.58) participated in this research.
Table 1 shows the demographic characteristics of the
patients.
The spouses were reported as the main supporting per-
son in the control and intervention group with a relative
frequency of 89.1% and 75.6%, respectively.
The most frequency distributions of medication adher-
ence items of MMAS in the intervention group before
and after intervention were as follows:
A 46.7% rate of cutting back or stopping medicine
treatment, due to no recovery, without informing the
doctor reduced to 2.2%. Also, an occasional forgetting to
take medication had a significant reduction from 91.1%
to 22.2%. Likewise, feeling hassled about sticking to
treatment plan had a reduction of 4.5%.
On the other hand, the distributions of participants’
adherence to prescribed medication based on the items
of MMAS in the control group in the first and second
assessment were like bellow:
Cut back or stopped taking medicine without consulting
with the doctor, because of no improvement after medica-
tion, decreased from 39.1% to 26.1%. The occasional
missing to take medicine increased from 73.9% to 80.4%.
Table 2 Comparison of mean variables before and after intervention in intervention group and in first and second
assessment in control group
Group Intervention group mean ± SD n T P Control group mean ± SD n T P
Before After First assess Second assess
Variable
MMAS (score) 3.1 ± 1.5 6.5 ± 1.6 45 −10.76 <.001 3.8 ± 1.0 3.3 ± 1.5 46 1.91 .06
DSSQ (score) 13.9 ± 6.5 24.8 ± 7 45 −8.67 <.001 14.3 ± 4.5 11.6 ± 3.2 46 3.96 <.001
HbA1c (%) 8.9 ± 1.3 7.7 ± 1.1 45 8.34 <.001 7.8 ± .7 8.1 ± .8 46 −2.27 .02
NCT (second) 170.9 ± 72.7 152.9 ± 46.3 45 2.89 <.006 189.2 ± 72.1 201.1 ± 68.7 46 −1.75 .08
MMAS: Morisky Medication Adherence Scale.
DSSQ: Diabetes Social Support Questioner.
NCT: number connection test.
Table 3 Comparison of mean changes of DSSQ, MMAS,








MMAS(score) ↑3.3 ± 2.0 ↓-.54 ± 1.9 9.25 <.001
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an increase of 2/2% (from 84.8% to 87%).
The most frequency distribution of family support
behavior items of DSSQ with “never” answer in inter-
vention group before and after intervention respectively
were: family members give you your medicine (reduction
of 88.9% to 11.1%). Family members help out when you
give yourself medicine (reduced rate of 77.8% to 11.1%).
Family member wake you up so you can take your morn-
ing medicine on time (reduction of 88.9% to 33.3%).
The most frequency distribution of family support
behavior items of DSSQ with “never” answer in control
group in the first and second assessment were respect-
ively: family members give you your medicine (reduction
of 95.7% to 80.4%). Family members help out when you
give yourself medicine (reduced rate of 80.4% to 71.2%).
Family member wake you up so you can take your morn-
ing medicine on time (increased rate of 89.1% to 97.8%).
Table 2 shows the comparison of mean MMAS, DSSQ-
family, cognitive, and hemoglobin A1C before and after
intervention in intervention group and in first assess and
after three months assessment in control group.
In control group there was no correlation between
DSSQ scores and MMAS scores, age, NCT scores and
diabetes duration in first assess and after three months
assessment.
In intervention group a significant correlation was noted
between DSSQ scores and MMAS scores after interven-
tion (r =0.67, P < 0.001) but, there was no correlation
between DSSQ scores and age, NCT scores and diabetes
duration before and also after intervention.
Table 3 shows a comparison of mean changes of
DSSQ, MMAS, NCT and hemoglobin A1C before and
after intervention in two groups.DSSQ(score) ↑10.9 ± 8.8 ↓-2.6 ± 4.4 9.57 <.001
NCT(second) ↓-18.0 ± 41.8 ↑11.8 ± 45.6 −3.25 .002
HbA1c(%) ↓-1.2 ± .9 6 ↑.3 ± .91 7.63 <.001
MMAS: Morisky Medication Adherence Scale.
DSSQ: Diabetes Social Support Questioner.
NCT: number connection test.
↑: Increase in mean.
↓: Decrease in mean.Discussion
The purpose of this study was to determine the impact of
family support improvement behaviors on anti diabetic
medication adherence and cognition in type 2 diabetic
patients.Family and social support are critical in managing
diabetes treatment [28-30]. There is a lack of research
regarding what family members know and feel about
type 2 diabetes [31,32] and the potential influence of fam-
ily members on the individual with type 2 diabetes has not
yet been fully explored [33,34]in particular, the indirect
effects of family members on cognition through improving
medication adherence has not been well identified.
In this study, there was a significant difference between
the mean score of family support (DSSQ) before and after
intervention (P < 0.001) which increased to10.9 ± 8.84
after intervention. There was also a significant difference
between the mean score of family support (P < 0.001) in
two time assessments in the control group, but the mean
change decreased to 2.63 ± 4.49 in 3 months later assess-
ment. Most theories of health behavior changes require
for diabetes self-care performance including a social
support component [35,36] in which family members
are all considered as a significant source of social sup-
port in adult with diabetes [31,37]. Family members can
have a positive and or negative impact on the health of
people with diabetes, interfere with or facilitate self care
activities [38]. Greater social support has been shown
to be associated with improved health outcomes and
healthier behavior [39].
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control group may derive from the changeable support-
ive behavior of family members who don’t know how to
help patients.
The results of this study indicated that there was a
significant positive correlation between MMAS scores
and DSSQ scores in intervention group while in control
group there was no correlation. The parallel finding of
previous study has shown that social support has been
found to be an influencing factor on medication adherence,
moreover members of more supportive families might have
healthier behaviors, higher medication adherence and low
levels of stress that could explain their superior outcome.
Thus, involving family members may improve the manage-
ment of diabetes [21]. The result of Scheurer et al. study
evaluating the association between social support and
medication adherence showed that, of 12 studies, 8 studies
identified the significant association of support and adher-
ence and for emotional support, of 14 studies, 6 surveys
identified a significant association between any emotional
support and adherence [39].
The results of present study showed the mean change
of hemoglobin A1c decreased%1.2 ± 0.96 in intervention
group and increased to%0.3 ± 0.91 in control group
(p < 0.001). This finding may be as a result of better adher-
ence to medication in intervention group. Mounting
evidences show that psychological family-based interven-
tion for patients with poorly controlled type 2 diabetes led
to an improvement in glycaemic control [40].
This study revealed that the mean change of NCT
score decreased in intervention group and increased in
control group. Hyperglycaemia and high hemoglobin
A1C levels [11] can cause cerebrovascular diseases and
cognitive impairment [41]. Lowton et al. found that non
adherence is more related to patient forgetfulness rather
than to specific concerns about medications or interaction
with physicians [1]. The condition along with chronic
hyperglycaemia, commonly found in the sufferers, may
result in cognitive improvement mainly in executive
functions, memory, attention and psychomotor activity
and disability in long term [11,42]. This can negatively
affect the patient adherence to diabetes treatment [12].
Recent evidence suggests that the inclusion of a family
member in psychosocial intervention chronic illness
may improve illness outcome [43]. Many patients do
not follow their medication orders and family support
may improve the medication adherence, this may be a
non-liner effect of family support on cognitive improve-
ment through medication adherence.
Conclusion
The results revealed that family support helps to improve
medication adherence and cognitive status in patients with
type 2 diabetes. Cognitive decline due to the presence of arisk factor of type 2 diabetes may occur as a result of
hyperglycaemia. Family support may enhance medication
adherence which results in glycaemic control and cogni-
tive improvement as an indirect effect of family support.
The results can help health care provider while counseling
family member of people with type 2 diabetes. They can
inform the family members about their effective roles and
also teach them some techniques for improving their
supportive behaviors.
It is suggested to study a naturally occurring social
construct such as family support in patients with higher
medication adherence and lower cognitive disorders to
better understanding these conditions and apply it in
artificially induced situations.
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